Search the Newsreel

Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M

* Citius Pharmaceuticals press release [https://seekingalpha.com/pr/20620155-citius-pharmaceuticals-inc-reports-fiscal-third-quarter-2026-financial-results-and-provides] (CTXR [https://seekingalpha.com/symbol/CTXR]): Q3 GAAP EPS of -$0.34 misses by $0.09. * Revenue of $1.5M misses by $8.27M. * Cash and cash equivalents of $17.0 million as of June 30, 2026. MORE ON CITIUS PHARMACEUTICALS * Seeking Alpha’s Quant …

Medallion Metals (ASX:MM8) Shares up Nearly 8% Today, Lounge Lizard Gold Mineralisation Results in Focus

Altius Minerals (TSX:ALS) Grew Q2 Sales And Net Income, Is It Fully Priced?

Impact Minerals Launches Renounceable Rights Issue to Fund HPA Growth Strategy

RKLB Stock Rises Overnight: Rocket Lab’s First 8 Satellites From $143M Globalstar Deal Reach Orbit

Rocket Lab's stock (RKLB) rose overnight after the company confirmed that the first eight satellites built under its $143 million contract with MDA Space successfully reached orbit. These satellites, part of a 17-platform deal, will support Globalstar’s direct-to-device communications and IoT services. The successful …

Gujarat Fluorochemicals Limited (NSE:FLUOROCHEM) Released Earnings Last Week And Analysts Lifted Their Price Target To ₹4,624

Stelar Metals Secures Approvals and Driller for Maiden Tungsten Program at Hill of Leaders

Mangalore Refinery & Petrochemicals Ltd. Downgraded to Hold Amid Mixed Technical and Financial Signals

Ragnar Metals Uncovers Multiple High-Grade Gold Shoots at Harnäs Project

Why Did ICL Group (ICL) Move Today?

ICL Group (NYSE:ICL) recently reported Q2 2026 sales of US$2,135 million and net income of US$137 million, alongside approving a new operating model. This news has led to a 9.90% share price increase over 30 days, although the stock is still down over longer …

Is Triple Flag Precious Metals (TSX:TFPM) Cheap After Strong Results, Guidance And A Dividend Raise?

Vanda Prepares BYSANTI Launch As Patent Protection Extends To 2044

Vanda Pharmaceuticals is set to launch BYSANTI in the second half of 2026 following FDA approval for bipolar I disorder and schizophrenia, with patent protection extending until May 2044. The company also reported strong Q2 Fanapt sales growth and has several late-stage pipeline readouts …

Applied Materials Trades More Than 25% Below Its High With Revenue at a Record

Applied Materials (NASDAQ: AMAT) came into Thursday's fiscal third-quarter report about 28% beneath its 52-week high of $739.67, closing the session at $534.54. The chip-equipment maker then posted records on nearly every line. Revenue came in at $9.1 billion, up 25% year over year. …

Why Tarsus Pharmaceuticals (TARS) Is Up 6.8% After Raising XDEMVY 2026 Sales Guidance - And What's Next

Tarsus Pharmaceuticals (TARS) saw its stock rise by 6.8% after reporting strong second-quarter 2026 results and raising its 2026 XDEMVY net product sales guidance to US$685 million–US$705 million. This increase signals management's confidence in XDEMVY's commercial trajectory, though the company still faces risks associated …

MDA SPACE SATELLITES FOR GLOBALSTAR SUCCESSFULLY LAUNCHED

First set of eight satellites for Globalstar 2-R mission deployed to low Earth orbit on a SpaceX Falcon 9 rocket, marking the beginning of the commissioning phase TORONTO, Aug. 16, 2026 /CNW/ -- MDA Space Ltd. (TSX: MDA) (NYSE: MDA), a leading provider of …

Globalstar Confirms Successful Launch of All 8 HIBLEO-4 Replacement Satellites

Globalstar, Inc. Satellites launched aboard SpaceX Falcon 9 rocket reach orbital plane Globalstar HIBLEO-4 LaunchGlobalstar confirms the successful launch of all 8 HIBLEO-4 replacement satellites aboard SpaceX Falcon 9 rocket. COVINGTON, La., Aug. 16, 2026 (GLOBE NEWSWIRE) -- Globalstar (NASDAQ: GSAT), a next-generation telecommunications …

Globalstar Announces Successful Launch and Deployment of Latest LEO Satellites

Globalstar successfully launched and deployed its latest low Earth orbit (LEO) satellites, marking a significant expansion of its constellation. All satellites are performing as expected after reaching their intended orbits and establishing communication with the Satellite Operations Command Center. These new satellites will undergo …

94,594 Shares in Air Products and Chemicals, Inc. $APD Purchased by S&CO Inc.

S&CO Inc. has acquired 94,594 shares of Air Products and Chemicals (NYSE:APD) for approximately $27.7 million, making it their 17th largest holding. The company recently reported strong quarterly earnings, beating analyst estimates with an EPS of $3.47 and a 4.6% year-over-year revenue increase. Analysts …

SCS Capital Management LLC Acquires Shares of 66,533 Vulcan Materials Company $VMC

SCS Capital Management LLC has purchased 66,533 shares of Vulcan Materials Company, valued at approximately $19.6 million, increasing institutional ownership to 90.39%. Vulcan Materials reported strong quarterly earnings of $2.59 per share, surpassing estimates, and declared a quarterly dividend of $0.52 per share. The …

Fiverr, Procter & Gamble, Martin Marietta: 52-Week Low Stocks Analysis - News and Statistics

USA Financial Formulas Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN

USA Financial Formulas has acquired a new stake in Regeneron Pharmaceuticals (NASDAQ:REGN), purchasing 1,457 shares valued at approximately $1.13 million, making it their 27th-largest portfolio holding. Institutional investors collectively own 83.31% of Regeneron, with several major firms significantly increasing their positions. The company recently …

Oppenheimer Asset Management Inc. Buys New Position in CSW Industrials, Inc. $CSW

Oppenheimer Asset Management Inc. has acquired a new position of 14,518 shares in CSW Industrials, Inc. (NYSE:CSW), valued at approximately $4.04 million. CSW Industrials recently reported strong quarterly earnings, beating analyst estimates with an EPS of $3.84 and a 33% year-over-year revenue increase. The …

AMAT Q2 Deep Dive: AI Demand and Advanced Packaging Drive Guidance Upside, Market Reacts Cautiously

AMAT Q2 Deep Dive: AI Demand and Advanced Packaging Drive Guidance Upside, Market Reacts Cautiously Semiconductor machinery manufacturer Applied Materials (NASDAQ:AMAT) announced better-than-expected revenue in Q2 CY2026, with sales up 24.8% year on year to $9.12 billion. On top of that, next quarter's revenue …

GSA Capital Partners LLP Purchases New Shares in Commercial Metals Company $CMC

GSA Capital Partners LLP has acquired a new stake of 33,406 shares in Commercial Metals Company (NYSE:CMC), valued at approximately $2.096 million. Other institutional investors have also adjusted their positions, and insider activity shows the CEO and a director purchasing shares. The company recently …

13,576 Shares in Eagle Materials Inc $EXP Bought by GSA Capital Partners LLP

GSA Capital Partners LLP recently acquired a new stake of 13,576 shares in Eagle Materials Inc (NYSE:EXP), valued at approximately $3.055 million, during the second quarter. Other institutional investors also adjusted their holdings in the company, with notable increases from EverSource Wealth Advisors LLC, …

Is Ionis Pharmaceuticals (IONS) Undervalued Following Its Pullback?

Commonwealth Retirement Investments LLC Reduces Holdings in Applied Materials, Inc. $AMAT

Ionis (IONS) Stock Looks Like A Bargain On Value But Full On Sales

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Ionis Pharmaceuticals stock carries a strong three year return record alongside a high overall value score, yet current market multiples still point to the shares …

Eagle Materials Inc (NYSE:EXP) Given Average Rating of "Hold" by Brokerages

Eagle Materials Inc. (NYSE:EXP) has received an average "Hold" rating from ten brokerages, with nine analysts recommending a hold and one a buy. The average 12-month price target is $222.56, slightly above its current share price of $208.35. The company's recent quarterly earnings missed …

Phathom Pharmaceuticals (PHAT) Stock Sees Modest Fair Value Cut After Analyst Target Cuts

Phathom Pharmaceuticals (PHAT) has experienced a modest fair value cut from US$23.70 to US$21.50 following analyst target revisions. This adjustment is due to updated Q2 results, revised 2026 revenue guidance, and new perspectives on their drug Voquezna's commercial path. While some firms remain bullish …

Applied Digital Corporation (NASDAQ:APLD) Receives Average Recommendation of "Moderate Buy" from Brokerages

Applied Digital Corporation (NASDAQ:APLD) has received an average "Moderate Buy" recommendation from brokerages, with an average 12-month price target of $68.15. Despite a significant year-over-year revenue increase of 406.3%, the company missed EPS estimates, reporting a loss of $0.39 against an expected loss of …

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Rating of "Moderate Buy" by Brokerages

Tarsus Pharmaceuticals (NASDAQ:TARS) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $90.50, significantly higher than its current share price of $69.20. The company recently reported quarterly revenue of $173.91 million, surpassing estimates, but its loss per …

Citius Pharmaceuticals Reports LYMPHIR Revenue Growth, Explores CAR-T Combination

Citius Pharmaceuticals reported promising early results for its approved drug LYMPHIR in new indications, including an 86% objective response rate in a Phase 1 CAR-T combination trial for diffuse large B-cell lymphoma and a 24% ORR in gynecologic malignancies. The company also announced strong …